Who is covered: Employers using more than one kilogram of MBOCA (regardless of concentration, dilution, or form, except frozen premix) in any 6-month period; authorized persons handling MBOCA [5215(d)(1)]
Evaluation performed by: Licensed physician (examinations by or under the supervision of) [5215(k)]
🩺 Baseline / Pre-Placement
Prior to the time of initial assignment, or within 90 days of the standard's effective date [5215(k)(1)]
- Comprehensive medical history with emphasis on pertinent medical, occupational, genetic, and environmental factors [5215(k)(2)]
- Comprehensive physical examination with emphasis on detecting abnormalities of the liver, pulmonary system, urinary system, breasts, and hematologic system [5215(k)(2)]
- Chest X-ray (14×17 PA)
- Complete blood count (CBC)
- Complete urinalysis
- Liver function tests: serum total bilirubin, alkaline phosphatase, and SGOT/SGPT
- Urine MBOCA biological monitoring (specific gravity adjusted to 1.024)
- NOTE: urine cytology is NOT required by this standard
🕒 Periodic / Routine
Interval-based while covered — NOT result-triggered
Schedule: At least every 3 years for the first 10 years of employment involving the use of MBOCA, and annually thereafter [5215(k)(1)].
- Updated comprehensive medical history (medical/occupational/genetic/environmental factors)
- Comprehensive physical examination emphasizing liver, pulmonary, urinary, breast, and hematologic systems
- Chest X-ray (14×17 PA)
- Complete blood count (CBC)
- Complete urinalysis
- Liver function tests: total bilirubin, alkaline phosphatase, SGOT/SGPT
- Urine MBOCA biological monitoring
- NOTE: NO urine cytology
Abnormal results & exposure-event protocols
Abnormal Results & Exposure-Event Protocols
- Urine MBOCA exceeds the 100 µg/L biological exposure limit (or another abnormal biological result) 8 CCR 5215(c)/(k) — biological monitoring response: Repeat the abnormal biological measurement (recommended within ~30 days) and investigate exposure controls; the standard provides no mandatory medical-removal criterion, so withdrawal from exposure is discretionary based on physician judgment. Tests: Repeat urine MBOCA determination, Physician evaluation of liver/urinary/hematologic status
Reporting Requirements
| Who performs the evaluation | Licensed physician |
|---|---|
| Reported to employer | Written opinion of the examining physician regarding the employee's medical status relative to MBOCA exposure (occupationally pertinent findings). |
| Reported to / for the employee | Physician must provide a copy of the written opinion to the affected employee [5215(k)]. |
| Time limits | Standard requires the written opinion be provided to the employee; a specific day-count is not stated in the verified text. |
| Second-opinion / multi-physician review | No multiple-physician review mechanism specified. |
| Recordkeeping | Physician opinions/records retained for the duration of employment plus 20 years, or 30 years, whichever is longer [5215(l)(6)]. |
Medical Removal Protection
No mandatory medical removal protection criterion. Abnormal biological (urine MBOCA) results prompt repeat testing and exposure-control review; withdrawal is at physician discretion.